Silicon Drugs & Intermediates Private Limited

Silicon Drugs & Intermediates Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN U24100TG2011PTC072926 Incorporated 25 February 2011 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹23,000
▲ 475.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹3.3 Cr
Registered with MCA
Paid-up capital
₹2.63 Cr
Issued & subscribed
Open charges
₹7.5 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Employees · EPFO
7
Latest available

About Silicon Drugs & Intermediates Private Limited

Data last updated: 18 February 2026

Silicon Drugs & Intermediates Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 25 February 2011, the company has been in operation for over 15 years.

Registered with ROC Hyderabad under CIN U24100TG2011PTC072926.

Capital: an authorised share capital of ₹3.3 Cr and a paid-up capital of ₹2.63 Cr. It is led by directors including Addanki Siva Rama Prasad and Gade Bakki Reddy.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Hyderabad, Telangana.

As per the financials filed for FY 2025, the company reported a revenue of ₹23,000, reflecting significant growth compared to the previous year.

The company has a workforce of approximately 7 employees as per the latest available data.

As per MCA filings, the company has open charges of ₹7.5 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Silicon Drugs & Intermediates Private Limited
CIN U24100TG2011PTC072926
Registration Number 072926
Incorporation Date 25 February 2011
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    H No. 2 – 52/2/24 Plot No 24 Sy No 60 Megha Hills Colony Guttalabegumpet (V) Serilingampa, Lly, Hyderabad, Telangana, India – 500081
  • Industry
    Pharma, Drug Formulation & Development
Company report
Silicon Drugs & Intermediates Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Silicon Drugs & Intermediates Private Limited report

Financials, compliance, directors, charges, ownership and filings for Silicon Drugs & Intermediates Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Silicon Drugs & Intermediates Private Limited

Silicon Drugs & Intermediates Private Limited has one previous CIN (Corporate Identification Number): U24100AP2011PTC072926. The current CIN is U24100TG2011PTC072926, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24100TG2011PTC072926 Current
U24100AP2011PTC072926 Previous

Business Activity of Silicon Drugs & Intermediates Private Limited

Silicon Drugs & Intermediates Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Silicon Drugs & Intermediates Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Silicon Drugs & Intermediates Private Limited

Silicon Drugs & Intermediates Private Limited is audited by B.R.M.REDDY & CO for the financial year 2021. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
B.R.M.REDDY & CO Locked Locked Locked
Premium access

Complete auditor history for Silicon Drugs & Intermediates Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Silicon Drugs & Intermediates Private Limited

Silicon Drugs & Intermediates Private Limited is currently managed by 3 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Addanki Siva Rama Prasad Director 25 Feb 2011 15 Years 5 Months Current
Gade Bakki Reddy Director 25 Feb 2011 15 Years 5 Months Current
Siva Nagi Reddy Vuyyuru Director 25 Feb 2011 15 Years 5 Months Current

Financials of Silicon Drugs & Intermediates Private Limited FY 2025 filings available

Silicon Drugs & Intermediates Private Limited reported revenue of ₹23,000 (up 475.00% YoY) for FY 2025.

Revenue · FY 2025
₹23,000 ▲ 475.00%
Premium access

Ten-year financial statements for Silicon Drugs & Intermediates Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Silicon Drugs & Intermediates Private Limited

Premium access

Shareholding and ownership data for Silicon Drugs & Intermediates Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Silicon Drugs & Intermediates Private Limited

Open charges
₹7.5 Cr
Satisfied charges
₹0
Breakdown by lending institutions
State Bank of India₹7.50 Cr
Latest charge details
DateLenderAmountStatus
16 May 2011 State Bank of India ₹7.5 Cr Open

Total charge records: 1 View all charges

Employees and EPFO Compliance at Silicon Drugs & Intermediates Private Limited

Silicon Drugs & Intermediates Private Limited has a workforce of 7 employees as of Apr 07, 2024.

Employee count
7
Active EPFO establishments
1
Employee growth
-41.67%
Premium access

Employee and EPFO history for Silicon Drugs & Intermediates Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Silicon Drugs & Intermediates Private Limited

Premium access

GST registrations and filing compliance for Silicon Drugs & Intermediates Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Silicon Drugs & Intermediates Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Silicon Drugs & Intermediates Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Silicon Drugs & Intermediates Private Limited

Premium access

MSME payment history for Silicon Drugs & Intermediates Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Silicon Drugs & Intermediates Private Limited

Premium access

Corporate group structure for Silicon Drugs & Intermediates Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Silicon Drugs & Intermediates Private Limited

Premium access

MCA filings and documents for Silicon Drugs & Intermediates Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Silicon Drugs & Intermediates Private Limited

Activity
30 Sep 2025
Silicon Drugs & Intermediates Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Silicon Drugs & Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
16 May 2011
A charge with State Bank Of India amounted to Rs. 7.50 Cr with Charge ID 10295192 was registered on 16 May 2011.
Directors
25 Feb 2011
Addanki Siva Rama Prasad was appointed as a Director on 25 Feb 2011 & has been associated with this company since 15 years 5 months.
Directors
25 Feb 2011
Gade Bakki Reddy was appointed as a Director on 25 Feb 2011 & has been associated with this company since 15 years 5 months.
Directors
25 Feb 2011
Siva Nagi Reddy Vuyyuru was appointed as a Director on 25 Feb 2011 & has been associated with this company since 15 years 5 months.

Frequently Asked Questions about Silicon Drugs & Intermediates Private Limited

Silicon Drugs & Intermediates Private Limited is an active private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 25 February 2011 (15+ years old) and is registered under CIN U24100TG2011PTC072926. The company has 7 employees.

Silicon Drugs & Intermediates Private Limited reported revenue of ₹23,000 for FY 2025 (up 475.00% YoY).

The current directors of Silicon Drugs & Intermediates Private Limited are:

The primary industry of Silicon Drugs & Intermediates Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Silicon Drugs & Intermediates Private Limited can be reached at the registered office: H No. 2 – 52224 Plot No 24 Sy No 60 Megha Hills Colony Guttalabegumpet V Serilingampa, Lly, Hyderabad, Telangana, India – 500081.

The authorised capital is ₹3.3 Cr, and the paid-up capital is ₹2.63 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available